March 11, 2010 – The FDA has cleared the first low-profile, premounted, balloon-expandable stent system for use in treating iliac artery disease. The Express LD Iliac Stent is designed to be highly deliverable, and balance strength, flexibility and conformability.
March 11, 2010 - A new PET/CT (postitron emission tomography/computed tomography) system provides imaging for both the clinical areas of both radiology and oncology.
March 11, 2010 – The FDA cleared a new family of introducers which offer features intended to minimize trauma to the artery and set the stage for closure using a closure device. The products also recently gained European CE mark approval.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Vascular Solutions offers a variety of hemostasis products used to stop bleeding. D-Stat products rely on biologically active components to induce bleeding cessation.The products use thrombin, a natural component of the clotting cascade. Thrombin cleaves fibrinogen to fibrin, enhancing the body's own ability to produce clot. D-Stat Dry
March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta.
Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only medication is intended for patients who cannot control their cholesterol levels by diet and exercise alone.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 10, 2010 - To help clinicians communicate about radiation dose exposure during radiological procedures, a new dose-saving solution for use in interventional radiology procedures is now available.
Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to fight cholesterol by focusing on the digestive tract.
An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries and chest pain.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Lowering radiation dose and improving navigation abilities of angiography systems have been among the top priorities of manufactures over the past year. Another big trend is integration of angiography systems in hybrid cath lab/operating rooms (ORs) as collaboration between surgeons and interventionalists improves with increasingly less-invasive procedures.
Editor’s note: Jerome Granato, M.D., is the medical director of the coronary care unit at Allegheny General Hospital in Pittsburgh, Pa. His facility started looking at ways to cut its nosocomial infection rates several years ago. This issue has a broader importance today, with CMS now cutting reimbursements for hospital-acquired infections and other “never events.”
The FDA’s approval of the Melody valve is widely viewed as a positive sign that may help other transcatheter valves to follow.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The FDA recently gave market clearance for Medtronic’s Melody Transcatheter Pulmonary Valve, the first transcatheter valve approved in the United States. The cardiology community expects this to be the first of many transcatheter valves to come, which are predicted to replace open-heart surgery with much less-invasive cath lab procedures.
March 10, 2010 - The third annual Workstation Face-Off at the 22nd European Congress of Radiology, held in Vienna, Austria, and hosted by radiologists Anno Graser M.D., and Christoph Becker, M.D., of the Ludwig-Maximillians University in Munich, featured two challenging cases involving oncology and perfusion imaging and analysis with CT and PET, for three sequential timepoints.
As cutting-edge technologies collide with innovative surgical and interventional treatments for multiple coronary or vascular issues, a hybrid approach is emerging as the best path of action.